Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 52197-12-3 Chemical Structure| 52197-12-3

Structure of 52197-12-3

Chemical Structure| 52197-12-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 52197-12-3 ]

CAS No. :52197-12-3
Formula : C7H4N4
M.W : 144.13
SMILES Code : N#CC1=NC=C(C)N=C1C#N
MDL No. :MFCD00191635
InChI Key :RHYUBLSWHDYKAO-UHFFFAOYSA-N
Pubchem ID :300516

Safety of [ 52197-12-3 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301+H311+H331-H315-H319
Precautionary Statements:P501-P261-P270-P271-P264-P280-P337+P313-P305+P351+P338-P361+P364-P332+P313-P301+P310+P330-P302+P352+P312-P304+P340+P311-P403+P233-P405
Class:6.1
UN#:2811
Packing Group:

Computational Chemistry of [ 52197-12-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 0
Num. H-bond acceptors 4.0
Num. H-bond donors 0.0
Molar Refractivity 36.43
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

73.36 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.06
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.29
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.53
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-1.69
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.23
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.28

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.32
Solubility 6.9 mg/ml ; 0.0479 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.39
Solubility 5.84 mg/ml ; 0.0405 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.19
Solubility 0.935 mg/ml ; 0.00649 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

Yes
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.97 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.03

Application In Synthesis of [ 52197-12-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 52197-12-3 ]

[ 52197-12-3 ] Synthesis Path-Downstream   1~35

  • 2
  • [ 52197-12-3 ]
  • [ 119298-80-5 ]
  • 3
  • [ 1187-42-4 ]
  • [ 78-98-8 ]
  • [ 52197-12-3 ]
  • 4
  • [ 79-14-1 ]
  • [ 52197-12-3 ]
  • [ 192933-53-2 ]
  • 5
  • [ 579-98-6 ]
  • [ 52197-12-3 ]
  • [ 192933-29-2 ]
  • 6
  • [ 28750-70-1 ]
  • [ 52197-12-3 ]
  • [ 192933-31-6 ]
  • 7
  • [ 142312-07-0 ]
  • [ 52197-12-3 ]
  • [ 192933-34-9 ]
  • 8
  • [ 78158-74-4 ]
  • [ 52197-12-3 ]
  • [ 192933-32-7 ]
  • 9
  • [ 192933-27-0 ]
  • [ 52197-12-3 ]
  • [ 192933-30-5 ]
  • 10
  • [ 887577-52-8 ]
  • [ 52197-12-3 ]
  • [ 192933-33-8 ]
  • 12
  • [ 120-21-8 ]
  • [ 52197-12-3 ]
  • 2,3-dicyano-5-[4-(diethylamino)styryl]pyrazine [ No CAS ]
  • 13
  • [ 52197-12-3 ]
  • [ 192933-54-3 ]
  • 14
  • [ 52197-12-3 ]
  • [ 192933-55-4 ]
  • 15
  • [ 52197-12-3 ]
  • [ 192933-56-5 ]
  • 16
  • [ 52197-12-3 ]
  • [ 192933-57-6 ]
  • 17
  • [ 52197-12-3 ]
  • [ 192933-38-3 ]
  • 18
  • [ 52197-12-3 ]
  • 1-methyl-2-amino-6-anilinomethyl-7-methylpteridin-4(1H)-imine [ No CAS ]
  • 19
  • [ 52197-12-3 ]
  • [ 192933-35-0 ]
  • 20
  • [ 52197-12-3 ]
  • [ 192933-40-7 ]
  • 21
  • [ 52197-12-3 ]
  • [ 192933-47-4 ]
  • 22
  • [ 52197-12-3 ]
  • N-(5-Cyano-6-ethylamino-3-methyl-pyrazin-2-ylmethyl)-N-phenyl-acetamide [ No CAS ]
  • 23
  • [ 52197-12-3 ]
  • N-[1-(6-Cyano-3-methyl-5-methylamino-pyrazin-2-yl)-ethyl]-N-phenyl-acetamide [ No CAS ]
  • 24
  • [ 52197-12-3 ]
  • N-(2-Amino-4-imino-1,7-dimethyl-1,4-dihydro-pteridin-6-ylmethyl)-N-phenyl-formamide [ No CAS ]
  • 25
  • [ 52197-12-3 ]
  • [ 192933-48-5 ]
  • 26
  • [ 52197-12-3 ]
  • 4-[(2-Amino-4-imino-1,7-dimethyl-1,4-dihydro-pteridin-6-ylmethyl)-amino]-benzonitrile [ No CAS ]
  • 27
  • [ 52197-12-3 ]
  • N-(6-Butylamino-5-cyano-3-methyl-pyrazin-2-ylmethyl)-N-phenyl-acetamide [ No CAS ]
  • 28
  • [ 52197-12-3 ]
  • N-[1-(2-Amino-4-imino-1,7-dimethyl-1,4-dihydro-pteridin-6-yl)-ethyl]-N-phenyl-formamide [ No CAS ]
  • 29
  • [ 52197-12-3 ]
  • [ 192933-36-1 ]
  • 30
  • [ 52197-12-3 ]
  • N-(2-Amino-4-imino-1,7-dimethyl-1,4-dihydro-pteridin-6-ylmethyl)-N-phenyl-acetamide [ No CAS ]
  • 31
  • [ 52197-12-3 ]
  • N-[1-(2-Amino-4-imino-1,7-dimethyl-1,4-dihydro-pteridin-6-yl)-ethyl]-N-phenyl-acetamide [ No CAS ]
  • 32
  • [ 52197-12-3 ]
  • 2-amino-6-(N-acetylanilino)methyl-1-ethyl-7-methylpteridin-4(1H)-imine [ No CAS ]
  • 33
  • [ 52197-12-3 ]
  • [ 192933-39-4 ]
  • 34
  • [ 52197-12-3 ]
  • 4-[(2-Amino-4-imino-1,7-dimethyl-1,4-dihydro-pteridin-6-ylmethyl)-amino]-benzoic acid methyl ester [ No CAS ]
  • 35
  • [ 52197-12-3 ]
  • 2-amino-6-(N-acetylanilino)methyl-1-butyl-7-methylpteridin-4(1H)-imine [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 52197-12-3 ]

Nitriles

Chemical Structure| 136309-04-1

A158662 [136309-04-1]

6-Methylpyrazine-2-carbonitrile

Similarity: 0.95

Chemical Structure| 98006-91-8

A578021 [98006-91-8]

5-Methylpyrazine-2-carbonitrile

Similarity: 0.76

Chemical Structure| 19847-12-2

A244035 [19847-12-2]

Pyrazine-2-carbonitrile

Similarity: 0.73

Chemical Structure| 2435-47-4

A149512 [2435-47-4]

3,6-Dimethylpyrazine-2-carbonitrile

Similarity: 0.71

Chemical Structure| 916333-43-2

A120753 [916333-43-2]

5-Acetylpyrazine-2-carbonitrile

Similarity: 0.64

Related Parent Nucleus of
[ 52197-12-3 ]

Pyrazines

Chemical Structure| 136309-04-1

A158662 [136309-04-1]

6-Methylpyrazine-2-carbonitrile

Similarity: 0.95

Chemical Structure| 14667-55-1

A136805 [14667-55-1]

2,3,5-Trimethylpyrazine

Similarity: 0.83

Chemical Structure| 123-32-0

A129340 [123-32-0]

2,5-Dimethylpyrazine

Similarity: 0.80

Chemical Structure| 108-50-9

A423470 [108-50-9]

2,6-Dimethylpyrazine

Similarity: 0.80

Chemical Structure| 15707-34-3

A152512 [15707-34-3]

5-Ethyl-2,3-dimethylpyrazine

Similarity: 0.77